Sequana Medical NV
SQNMF
$3.00
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -85.19% | -64.88% | -46.69% | -32.32% | -20.84% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -85.19% | -64.88% | -46.69% | -32.32% | -20.84% |
| Cost of Revenue | -83.89% | -63.36% | -44.53% | -29.68% | -17.71% |
| Gross Profit | -85.59% | -65.36% | -47.34% | -33.09% | -21.75% |
| SG&A Expenses | -34.19% | -27.31% | -20.32% | -7.09% | 4.82% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -50.00% | 2,580.00% | 1,280.65% | 562.34% | 102.33% |
| Total Operating Expenses | -37.69% | -29.51% | -21.22% | -7.44% | 5.13% |
| Operating Income | 36.55% | 28.60% | 20.52% | 6.70% | -5.97% |
| Income Before Tax | -38.34% | -13.25% | 13.43% | 1.60% | -8.55% |
| Income Tax Expenses | -39.76% | -24.44% | -5.36% | 10.02% | 22.00% |
| Earnings from Continuing Operations | -37.23% | -12.75% | 13.34% | 1.45% | -8.72% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -37.23% | -12.75% | 13.34% | 1.45% | -8.72% |
| EBIT | 36.55% | 28.60% | 20.52% | 6.70% | -5.97% |
| EBITDA | 36.81% | 28.87% | 20.80% | 6.91% | -5.82% |
| EPS Basic | 5.04% | 16.94% | 28.56% | 16.83% | 7.39% |
| Normalized Basic EPS | 4.29% | 16.63% | 28.64% | 16.94% | 7.53% |
| EPS Diluted | 5.04% | 16.94% | 28.56% | 16.83% | 7.39% |
| Normalized Diluted EPS | 4.29% | 16.63% | 28.64% | 16.94% | 7.53% |
| Average Basic Shares Outstanding | 37.26% | 30.67% | 23.48% | 20.64% | 17.59% |
| Average Diluted Shares Outstanding | 37.26% | 30.67% | 23.48% | 20.64% | 17.59% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |